1,098
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

The impact of risk perception and institutional trust on COVID-19 vaccine hesitancy in China

, , &
Article: 2301793 | Received 26 Oct 2023, Accepted 01 Jan 2024, Published online: 28 Jan 2024

References

  • Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF joint reporting form data-2015-2017. Vaccine. 2018;36(26):3861–7. doi:10.1016/j.vaccine.2018.03.063.
  • Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 2014;32(19):2150–9. doi:10.1016/j.vaccine.2014.01.081.
  • Löffler P. Review: vaccine myth-buster - cleaning up with prejudices and dangerous misinformation. Front Immunol. 2021;12:663280. doi:10.3389/fimmu.2021.663280.
  • Kumar D, Chandra R, Mathur M, Samdariya S, Kapoor N. Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res. 2016;5(1):2. doi:10.1186/s13584-016-0062-y.
  • Quinn SC, Jamison A, An J, Freimuth VS, Hancock GR, Musa D. Breaking down the monolith: understanding flu vaccine uptake among African Americans. SSM Popul Health. 2018;4:25–36. doi:10.1016/j.ssmph.2017.11.003.
  • Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin CY. et al. COVID-19 vaccine hesitancy in the United States: a systematic review. Front Public Health. 2021;9:770985. doi:10.3389/fpubh.2021.770985.
  • Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9:698111. doi:10.3389/fpubh.2021.698111.
  • Hudson A, Montelpare WJ. Predictors of vaccine hesitancy: implications for COVID-19 public health messaging. Int J Environ Res Public Health. 2021;18:15. doi:10.3390/ijerph18158054.
  • Andrade G. Predictive demographic factors of covid-19 vaccine hesitancy in Venezuela: a cross-sectional study. Vacunas. 2022;23:S22–s25. doi:10.1016/j.vacun.2021.07.009.
  • Samo AA, Sayed RB, Valecha J, Baig NM, Laghari ZA. Demographic factors associated with acceptance, hesitancy, and refusal of COVID-19 vaccine among residents of Sukkur during lockdown: a cross sectional study from Pakistan. Hum Vaccin Immunother. 2022;18(1):2026137. doi:10.1080/21645515.2022.2026137.
  • Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q, Long S, Zhang J, Jin H. Factors influencing vaccine hesitancy in China: a qualitative study. Vaccines (Basel). 2021;9(11):1291. doi:10.3390/vaccines9111291.
  • Zhang H, Zheng P, Zhang J, Qiu Q, Huang B, Feng H, Zhang Y, Chen X, Xu J, Dong X. Vaccine hesitancy among parents and its influencing factors: a cross-sectional study in Guangzhou, China. Hum Vaccin Immunother. 2021;17(12):5153–5161. doi:10.1080/21645515.2021.1984131.
  • Zou H, Huang Y, Chen T, Zhang L. Influenza vaccine hesitancy and influencing factors among university students in China: a multicenter cross-sectional survey. Ann Med. 2023;55(1):2195206. doi:10.1080/07853890.2023.2195206.
  • Zhou Y, Lin Z, Wan X, Liu J, Ding J, Zhang C, Ren K, Li D, Wu Y. COVID-19 vaccine acceptance and hesitancy in patients with Parkinson’s disease. Front Public Health. 2022;10:977940. doi:10.3389/fpubh.2022.977940.
  • Xu B, Zhang Y, Chen L, Yu L, Li L, Wang Q. The influence of social network on COVID-19 vaccine hesitancy among healthcare workers: a cross-sectional survey in Chongqing, China. Hum Vaccin Immunother. 2021;17(12):5048–5062. doi:10.1080/21645515.2021.2004837.
  • Chen Y, Zhang MX, Lin XQ, Wu H, Tung TH, Zhu JS. COVID-19 vaccine hesitancy between teachers and students in a college, a cross-sectional study in China. Hum Vaccin Immunother. 2022;18(5):2082171. doi:10.1080/21645515.2022.2082171.
  • Chen H, Li X, Gao J, Liu X, Mao Y, Wang R, Zheng P, Xiao Q, Jia Y, Fu H. et al. Health belief model perspective on the control of COVID-19 vaccine hesitancy and the promotion of vaccination in China: web-based cross-sectional study. J Med Internet Res. 2021;23(9):e29329. doi:10.2196/29329.
  • Zhuang W, Zhang J, Wei P, Lan Z, Chen R, Zeng C, Shi Q, Qiao G. Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients. Hum Vaccin Immunother. 2021;17(12):5016–5023. doi:10.1080/21645515.2021.1992212.
  • Brewer NT, Weinstein ND, Cuite CL, Herrington JE. Risk perceptions and their relation to risk behavior. Ann Behav Med. 2004;27(2):125–30. doi:10.1207/s15324796abm2702_7.
  • Johnson BB, Kim B. Cross-temporal relations of conditional risk perception measures with protective actions against COVID-19. Social Sci Med. 2023;324:115867. doi:10.1016/j.socscimed.2023.115867.
  • Giuntella O, Hyde K, Saccardo S, Sadoff S. Lifestyle and mental health disruptions during COVID-19. Proc Natl Acad Sci USA. 2021;118(9). doi:10.1073/pnas.2016632118.
  • Bendau A, Plag J, Petzold MB, Ströhle A. COVID-19 vaccine hesitancy and related fears and anxiety. Int Immunopharmacol. 2021;97:107724. doi:10.1016/j.intimp.2021.107724.
  • Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14(7):1599–1609. doi:10.1080/21645515.2018.1459252.
  • Siegrist M, Cvetkovich G, Roth C. Salient value similarity, social trust, and risk/benefit perception. Risk Anal. 2000;20(3):353–62. doi:10.1111/0272-4332.203034.
  • Wachinger G, Renn O, Begg C, Kuhlicke C. The risk perception paradox–implications for governance and communication of natural hazards. Risk Anal. 2013;33(6):1049–65. doi:10.1111/j.1539-6924.2012.01942.x.
  • Seddig D, Maskileyson D, Davidov E, Ajzen I, Schmidt P. Correlates of COVID-19 vaccination intentions: attitudes, institutional trust, fear, conspiracy beliefs, and vaccine skepticism. Social Sci Med. 2022;302:114981. doi:10.1016/j.socscimed.2022.114981.
  • Allington D, McAndrew S, Moxham-Hall V, Duffy B. Coronavirus conspiracy suspicions, general vaccine attitudes, trust and coronavirus information source as predictors of vaccine hesitancy among UK residents during the COVID-19 pandemic. Psychol Med. 2023;53(1):236–247. doi:10.1017/S0033291721001434.
  • Jennings W, Stoker G, Bunting H, Valgarðsson VO, Gaskell J, Devine D, McKay L, Mills MC. Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines (Basel). 2021;9(6):593. doi:10.3390/vaccines9060593.
  • Kang K, Xu X, Dong R, Tian G. The risk perception of COVID-19 and pandemic-related behaviors: a moderated mediation model of political trust and self-efficacy. Psychol Health Med. 2023;2023:1–14. doi:10.1080/13548506.2023.2197648.
  • Bussink-Voorend D, Hautvast JLA, Vandeberg L, Visser O, Hulscher M. A systematic literature review to clarify the concept of vaccine hesitancy. Nat Hum Behav. 2022;6(12):1634–1648. doi:10.1038/s41562-022-01431-6.
  • Sudharsanan N, Favaretti C, Hachaturyan V, Bärnighausen T, Vandormael A. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: a structured summary of a study protocol for a randomized controlled trial. Trials. 2021;22(1):592. doi:10.1186/s13063-021-05484-2.
  • Gentile A, Pacchiotti AC, Giglio N, Nolte MF, Talamona N, Rogers V, Berenstein A, Castellano VE. Vaccine hesitancy in Argentina: validation of WHO scale for parents. Vaccine. 2021;39(33):4611–4619. doi:10.1016/j.vaccine.2021.06.080.
  • Cheng L, Ma W, Xia X, Wang L. Quality-achieving reliability assessment of rolling bearing based on bootstrap maximum entropy method and similarity method. Sci Prog. 2022;105(2):368504221102737. doi:10.1177/00368504221102737.
  • Durmuş Sarıkahya S, Güden E, Sümeyye Yorulmaz D. Childhood vaccine hesitancy in two regions with different socioeconomic backgrounds in Turkey. Z Gesundh Wiss. 2023:1–0. doi:10.1007/s10389-023-01854-z.
  • Zhang X, Lin Z. Evaluation of water resource utilization efficiency in provincial areas of China based on the unexpected output SBM Model. J Environ Public Health. 2022;2022:9554730. doi:10.1155/2022/9554730.
  • Bastard P, Gervais A, Le Voyer T, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Sci Immunol. 2021;6:62. doi:10.1126/sciimmunol.abl4340.
  • Burki T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit Health. 2020;2(10):504–5. doi:10.1016/S2589-7500(20)30227-2.
  • Taylor S, Landry CA, Paluszek MM, Groenewoud R, Rachor GS, Asmundson GJG. A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2. Front Psychol. 2020;11:575950. doi:10.3389/fpsyg.2020.575950.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. doi:10.1038/s41591-020-1124-9.
  • Cipolletta S, Andreghetti GR, Mioni G. Risk perception towards COVID-19: a systematic review and qualitative synthesis. Int J Environ Res Public Health. 2022;19(8):4649. doi:10.3390/ijerph19084649.
  • Truong J, Bakshi S, Wasim A, Ahmad M, Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health Promot Int. 2022;37(1). doi:10.1093/heapro/daab105.
  • Schernhammer E, Weitzer J, Laubichler MD, Birmann BM, Bertau M, Zenk L, Caniglia G, Jäger CC, Steiner G. Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government. J Public Health (Oxf). 2022;44(1):106–16. doi:10.1093/pubmed/fdab122.
  • Nusair MB, Arabyat R, Khasawneh R, Al-Azzam S, Nusir AT, Alhayek MY. Assessment of the relationship between COVID-19 risk perception and vaccine acceptance: a cross-sectional study in Jordan. Hum Vaccin Immunother. 2022;18(1):2017734. doi:10.1080/21645515.2021.2017734.
  • Du F, Chantler T, Francis MR, Sun FY, Zhang X, Han K, Rodewald L, Yu H, Tu S, Larson H, et al. The determinants of vaccine hesitancy in China: a cross-sectional study following the Changchun Changsheng vaccine incident. Vaccine. 2020;38(47):7464–7471. doi:10.1016/j.vaccine.2020.09.075.
  • Burger J. Trust and consequences: role of community science, perceptions, values, and environmental justice in risk communication. Risk Anal. 2022;42(11):2362–2375. doi:10.1111/risa.14020.
  • Ennab F, Qasba RK, Uday U, Priya P, Qamar K, Nawaz FA, Islam Z, Zary N. COVID-19 vaccine hesitancy: a narrative review of four South Asian countries. Front Public Health. 2022;10:997884. doi:10.3389/fpubh.2022.997884.
  • Jin H, Wang H, Li X, Zheng W, Ye S, Zhang S, Zhou J, Pennington M. Economic burden of COVID-19, China, January–March, 2020: a cost-of-illness study. Bull World Health Organ. 2021;99(2):112–24. doi:10.2471/BLT.20.267112.
  • Mahajan R, Gupta P, Kushawaha PS. Role of digital misinformation in analysing COVID-19 vaccine hesitancy. Int J Manag Pract. 2023;16(3):284–318. doi:10.1504/IJMP.2023.130353.
  • Zhang M, Wang Y, Zhang T, Zhou J, Deng Y, Wang L, Du Y. Status of and perspectives on COVID-19 vaccination after lifting of the dynamic zero-COVID policy in China. Glob Health Med. 2023;5(2):112–17. doi:10.35772/ghm.2022.01063.
  • Fang E, Liu X, Li M, Zhang Z, Song L, Zhu B, Wu X, Liu J, Zhao D, Li Y. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther. 2022;7(1):94. doi:10.1038/s41392-022-00950-y.